Gleva vs Pep AI: Simple Tracking vs Pattern Finding
Pep AI is the simple end of GLP-1 tracking — reminders, a routine dashboard, oral GLP-1s included. Gleva is built around correlation. Compared honestly.
The honest disclaimer first
Pep AI is a released app with thousands of ratings. Gleva is in development and has not launched.
So this is not a head-to-head you can verify today. It is an explanation of where our approach differs, written by the people building the one that does not exist yet.
What Pep AI does
Pep AI is the simpler end of the category, and that appears to be on purpose. Shot logging, reminders, a routine dashboard, AI photo food recognition on the paid tier. It covers oral GLP-1s as well as injectables, and peptides beyond GLP-1s — two things that quietly rule out most of the competition if either applies to you.
It has less medication-level depth than the all-in-one trackers. Whether that reads as a limitation or as the entire point depends on what you actually want. Some people want the curve. Some people want a button and a reminder, and resent every screen between them and it.
Where the two differ
This is the comparison on this site where the honest answer is most likely to be "stay where you are".
Pep AI's design bet is that tracking should cost you five seconds a week. Gleva's bet is that the accumulated log is worth interrogating — that the interesting information is in the relationship between the dose, the day of the cycle, the injection site and the symptom, and that surfacing it is worth a slightly heavier record.
Those are opposite bets. If Pep AI's simplicity is why you like it, Gleva is answering a question you have not asked, and adding friction to buy an insight you do not want. That is a real and reasonable position.
The people the two products suit are genuinely different, which is not something we can say about every app on the comparison list.
The oral GLP-1 and peptide gap
This is the part of Pep AI's positioning that deserves more attention than it usually gets in comparison articles.
Almost every GLP-1 tracker is built around one assumption: you inject once a week, and the app's job is to organise your life around that seven-day cycle. Shot-day reminders, day-of-cycle charts, injection site rotation, weekly medication-level curves. It is a reasonable assumption because it describes most people.
It does not describe everyone. If you are on an oral GLP-1, the weekly cycle simply is not your shape — you take something daily, there is no injection site, and a tracker built around shot day will spend most of its screen space on questions that do not apply to you. The same goes for anyone whose regimen extends past a single GLP-1 into other peptides, where "which shot, which site, which day" becomes a genuinely more complicated record.
Pep AI covers both cases. That is a small sentence with a large practical consequence: it narrows the realistic field for those users from roughly a dozen apps to two or three. If either describes you, the rest of this comparison matters much less than that one fact.
The subscription question
Pep AI runs on a subscription, and that is worth weighing honestly rather than treating as a mark against it.
A subscription on a tracker you use weekly for a year or more adds up, and there is a real alternative — MounjaGO's one-time purchase, covered in its own comparison — for people who would rather pay once. On the other side, a subscription is what pays for an app to still work after the next OS update, which is not nothing in a category where abandoned trackers are common.
The question worth asking is not whether it costs money but whether you will still be using it in six months. Tracking tends to drop off sharply after the first few months of treatment. If you are the kind of person who logs diligently for eight weeks and then stops, a subscription is the wrong shape and a free tier is the right one. If you intend to keep the record for the length of your treatment, the cost per month of history is small.
Which to pick today
Today, Pep AI, because it exists — particularly if you are on an oral GLP-1 or tracking peptides beyond GLP-1s, where the field narrows sharply.
Come back to Gleva if you reach the point, usually somewhere in month three, where you have a log full of entries and no idea what it is telling you. That is the specific moment we are building for. Until then, what to log in your first month is more useful than switching trackers.
